HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
RS 8359
structure given in first source; RN given refers to (+-)-isomer; RN for cpd without isomeric designation not available 6/89
Also Known As:
4-(4-cyanophenyl)amino-6,7-dihydro-7-hydroxy-5H-cyclopenta(d)pyrimidine; RS-8359; Benzonitrile, 4-((6,7-dihydro-7-hydroxy-5H-cyclopenta(d)pyrimidin-4-yl)amino)-
Networked:
5
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
Nitriles: 227
RS 8359: 5
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Pyrimidines: 510
RS 8359: 5
Related Diseases
1.
Ischemia
04/01/1994 - "
Effects of repeated administration of RS-8359, (+-)-4-(4-cyanoanilino)-7-hydroxycyclopenta(3,2-e)pyrimidin e, (30 mg/kg x 2/day, p.o., 4 days) were examined at 3 days postischemia following 20 min of ischemia.
"
04/01/1994 - "
Effects of RS-8359 on reduced local cerebral glucose utilization in the rat subjected to transient forebrain ischemia.
"
12/01/1990 - "
RS-8359 pretreatment (30 mg/kg, p.o.) at an hour prior to ischemia elevated the levels of NE in the cortex and hippocampus during ischemia and inhibited the increases in DOPAC and HVA levels and the decrease in 3MT levels at 30 min after reperfusion.
"
12/01/1990 - "
Changes in monoamine levels during and after ischemia and effects of RS-8359, a type A monoamine oxidase (MAO-A) inhibitor, were studied in the cerebral cortex, hippocampus, and striatum of rats killed by microwave irradiation.
"
05/27/1991 - "
Pretreatment with type A monoamine oxidase (MAO-A) inhibitors, clorgyline and RS-8359 ((+)-4-(4-cyanoanilino)-7-hydroxycyclopenta (3,2-e) pyrimidine) decreased significantly the number of necrotic neurons and inhibited changes in the dopamine metabolite contents during and after transient ischemia.
"
2.
Major Depressive Disorder (Major Depressive Disorders)
09/01/1997 - "
Moreover, the data on auditory-evoked potentials suggest that RS-8359 may improve cognitive performance, which is often impaired in major depressive disorders.
"
3.
Brain Ischemia (Cerebral Ischemia)
03/01/1995 - "
TL, TF and STL decreased in rats receiving brain ischemia, and we found that after treatment with RS-8359, TL and TF increased, but no effect was observed on STL.
"
Related Drugs and Biologics
1.
Monoamine Oxidase (MAO)
2.
3,4-Dihydroxyphenylacetic Acid
3.
Glucose (Dextrose)
4.
Dopamine (Intropin)
5.
Clorgyline (Clorgiline)
6.
pyrimidine
Related Therapies and Procedures
1.
Aftercare (After-Treatment)